Platelet function study in heart surgery
Part of Blood & lymphatic clinical trials.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are scheduled for planned heart surgery that uses a heart-lung machine.
- You have signed a consent form and understood the procedure.
- Your health status is classified as ASA I, II, III, or IV.
- You have a normal blood clotting test and a normal platelet count before surgery.
- You have stopped taking certain blood thinners long enough before surgery (5 days for clopidogrel or ticagrelor, 7 days for prasugrel).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how heart-lung machines used during heart surgery affect blood platelets (clotting cells) and the body's inflammatory response. Understanding these changes may help doctors better manage bleeding and inflammation after cardiac surgery.
This trial tests if using your own donated platelets during complex heart surgery is safe and effective. If you are having major heart surgery, donating your own platelets beforehand might help you recover better.
This study tests a new blood test that measures how well your platelets (clotting cells) work to predict if you might bleed more after heart surgery. The goal is to catch bleeding problems early and help doctors manage them better.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
This study looks at special cells in your bone marrow and blood that help make platelets. Researchers want to learn more about these cells in people having planned heart bypass surgery. If you are eligible, you will donate some extra bone marrow and blood samples during your surgery.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.